A preclinical blood test, supported by NIH, predicts adults' risk for severe respiratory conditions like COPD by analyzing 32 proteins.

A preclinical blood test, developed with National Institutes of Health support, can predict adults' risk for severe respiratory conditions like chronic obstructive pulmonary disease (COPD). Analyzing 32 proteins, the test generates a risk score based on a 30-year study of nearly 2,500 U.S. adults. While not yet approved for clinical use, it shows promise for early identification of at-risk individuals, potentially improving lung health outcomes.

September 10, 2024
8 Articles

Further Reading